Advanced SearchSearch Tips
Treatment and Rehabilitation of Repetitively Recurrent Langerhans Cell Histiocytosis: A Case Report
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Korean Dental Science
  • Volume 9, Issue 1,  2016, pp.35-41
  • Publisher : Korean Academy of Dental Sciences
  • DOI : 10.5856/JKDS.2016.9.1.35
 Title & Authors
Treatment and Rehabilitation of Repetitively Recurrent Langerhans Cell Histiocytosis: A Case Report
Yoo, Hee Young; Park, Kyung Soo; Lee, Baek Soo; Kwon, Yong Dae; Choi, Byung Joon; Ohe, Joo Young; Lee, Jung Woo;
  PDF(new window)
Langerhans cell histiocytosis (LCH) is characterized by proliferation of histiocyte-like cells (Langerhans cell histiocytes) with characteristic Birbeck granules, accompanied by other inflammatory cells. Treatments of LCH include surgery, chemotherapy, and radiotherapy. One of the representative forms of chemotherapy is intralesional injection of steroids. Surgical treatment in the form of simple excision, curettage, or even ostectomy can be performed depending on the extent of involvement. Radiotherapy is suggested in case of local recurrence, or a widespread lesion. This article shows the case of repetitively recurrent LCH of a 56-year-old man who had been through surgical excision and had to have marginal mandibulectomy and radiotherapy when the disease recurred. After the first recurrence occurred, lesions involved the extensive part of the mandible causing pathologic fracture, so partial mandibular bone resection was performed from the right molar area to the left molar area followed by the excision of the surrounding infected soft tissues. The resected mandibular bone was reconstructed with a segment of fibula osteomyocutaneous free flap and overdenture prosthesis supported by osseointegrated implants.
Fibula osteomyocutaneous free flap;Histiocytosis;Langerhans cell;Reconstruction;Recurrence;
 Cited by
Nezelof C, Basset F, Rousseau MF. Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine. 1973; 18: 365-71.

Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012; 156: 163-72. crossref(new window)

Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, Bucsky P, Egeler RM, Elinder G, Gadner H, Gresik M, Henter JI, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J; The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997; 29: 157-66. crossref(new window)

Berry DH, Gresik MV, Humphrey GB, Starling K, Vietti T, Boyett J, Marcus R. Natural history of histiocytosis X: a pediatric oncology group study. Med Pediatr Oncol. 1986; 14: 1-5. crossref(new window)

Meyer JS, Harty MP, Mahboubi S, Heyman S, Zimmerman RA, Womer RB, Dormans JP, D'Angio GJ. Langerhans cell histiocytosis: presentation and evolution of radiologic findings with clinical correlation. Radiographics. 1995; 15: 1135-46. crossref(new window)

Cisternino A, Asa'ad F, Fusco N, Ferrero S, Rasperini G. Role of multidisciplinary approach in a case of Langerhans cell histiocytosis with initial periodontal manifestations. Int J Clin Exp Pathol. 2015; 8: 13539-45.

Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis: current concepts and treatments. Cancer Treat Rev. 2010; 36: 354-9. crossref(new window)

Glotzbecker MP, Carpentieri DF, Dormans JP. Langerhans cell histiocytosis: clinical presentation, pathogenesis, and treatment from the LCH Etiology Research Group at the Children's Hospital of Philadelphia. Univ Pa Orthop J. 2002; 15: 67-73.

Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006; 76: 363-8. crossref(new window)

Pollono D, Rey G, Latella A, Rosso D, Chantada G, Braier J. Reactivation and risk of sequelae in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007; 48: 696-9. crossref(new window)

Key SJ, O'Brien CJ, Silvester KC, Crean SJ. Eosinophilic granuloma: resolution of maxillofacial bony lesions following minimal intervention. Report of three cases and a review of the literature. J Craniomaxillofac Surg. 2004; 32: 170-5. crossref(new window)

Fiorini P, Gallesio C, Longoni V, Ramieri G. Eosinophilic granuloma of the mandible: is a conservative treatment sufficient for local disease control? J Craniofac Surg. 2016; 27: e255-7. crossref(new window)

Hartman KS. Histiocytosis X: a review of 114 cases with oral involvement. Oral Surg Oral Med Oral Pathol. 1980; 49: 38-54. crossref(new window)

Chomette G, Auriol M, Ragot JP, Guilbert F. Histiocytosis X of the jaw. I. Anatomico-clinical study apropos of 61 cases. Rev Stomatol Chir Maxillofac. 1987; 88: 334-8.

Bartnick A, Friedrich RE, Roeser K, Schmelzle R. Oral Langerhans cell histiocytosis. J Craniomaxillofac Surg. 2002; 30: 91-6. crossref(new window)

Gramatovici R, D'Angio GJ. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis). Med Pediatr Oncol. 1988; 16: 259-62. crossref(new window)

Taylor GI, Miller GD, Ham FJ. The free vascularized bone graft. A clinical extension of microvascular techniques. Plast Reconstr Surg. 1975; 55: 533-44. crossref(new window)

Hidalgo DA. Fibula free flap: a new method of mandible reconstruction. Plast Reconstr Surg. 1989; 84: 71-9. crossref(new window)

Frodel JL Jr, Funk GF, Capper DT, Fridrich KL, Blumer JR, Haller JR, Hoffman HT. Osseointegrated implants: a comparative study of bone thickness in four vascularized bone flaps. Plast Reconstr Surg. 1993; 92: 449-55; discussion 456-8. crossref(new window)